Pharma channel feed – Endpoints News

Pharma channel feed

Some generics, biosimilar drugmakers say they can withstand tariff impact

Last week

Watch Post-Hoc Live: Trump's 'most favored nation' plan to cut drug prices

Last week

Bayer starts 2025 by cutting 2,000 jobs as it homes in on year-end rehaul target

Last week

Pharma investors brush off Trump’s ‘most favored nation’ plan as stocks rise

Last week

Lack of detail in Trump's drug price plan raises more questions than answers

Last week

PBM overhaul and drug price negotiations make the cut in Republicans' tax bill

Last week

Roche could rethink $50B US expansion plan if new policies 'harm' operations

Last week

Updated: White House threatens ‘most favored nation’ plan to lower US drug prices, but many questions remain

Last week

Trump says he'll sign order on 'most favored nation' drug price plans Monday

Last week

Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi

3 weeks ago

Lonza says its US-based sites are in high demand as pharma tariffs near

3 weeks ago

Illumina confirms SEC has closed investigation into $8B Grail deal

3 weeks ago

Takeda announces handful of pipeline cuts in effort to ‘pivot resources’

3 weeks ago

Illumina forecasts $85M in tariff costs, decrease in China sales

3 weeks ago

AstraZeneca loses appeals court fight over IRA drug price negotiations

3 weeks ago

GSK awaits Nucala decision after FDA target date passes

3 weeks ago

FDA grants Verastem first approval for rare ovarian cancer treatment

3 weeks ago

FDA will convene vaccine advisors to discuss Covid strain updates

3 weeks ago

Gilead reveals plans to put another $11B into US manufacturing

3 weeks ago

Teva plans staff cuts as it commits to accelerating growth

3 weeks ago

PhRMA says tariffs are 'not the answer' as industry trade probe closes for comments

3 weeks ago

FDA's ODAC will review drugs for four different cancers at meeting in May

3 weeks ago

Avadel can pursue label expansion for narcolepsy drug Lumryz after court ruling

3 weeks ago

From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices

3 weeks ago

First page Previous page 1 234 5 6 Next page Last page